HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and economic results of ventriculoperitoneal shunt infections in children.

AbstractAIM:
This study evaluated the clinical and economic outcomes of ventriculoperitoneal shunt infections.
MATERIAL AND METHODS:
Patients diagnosed with ventriculoperitoneal shunt infections for the first time between 1 January 2007 and 31 December 2011 were included in this study. Demographic, clinical, and economic data were analyzed retrospectively. A cost coefficient (total cost/follow-up period) and hospitalization coefficient (duration of hospitalization/follow-up period) were calculated for each patient.
RESULTS:
In total, 132 shunt infections (mean follow-up, 734 ± 367 days) were evaluated in 51 patients (mean age, 16.6 ± 9.22 months; median age, 3 months; range, 1-88 months; 28 females, 21 males). In 23 patients (45%), shunt infections were seen in the first 2 months following shunt placement. Seven patients died during the follow-up. There was a negative correlation between the age at diagnosis and the hospitalization duration (p = 0.005, r = -0.381). The average cost of hospitalization per patient was 6397 ± 4338 TL. There was a negative correlation between the cost index and the age at diagnosis (p = 0.04, r = -0.292).
CONCLUSION:
Ventriculoperitoneal shunt infections have significant medical and economic impacts. Younger the diagnosis of patients, the hospitalization duration and treatment cost were higher.
AuthorsAli Kanik, Seda Sirin, Engin Kose, Kayı Eliacik, Murat Anil, Mehmet Helvaci
JournalTurkish neurosurgery (Turk Neurosurg) Vol. 25 Issue 1 Pg. 58-62 ( 2015) ISSN: 1019-5149 [Print] Turkey
PMID25640546 (Publication Type: Journal Article)
Topics
  • Age Factors
  • Child
  • Child, Hospitalized
  • Child, Preschool
  • Costs and Cost Analysis
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Length of Stay (economics)
  • Male
  • Meningitis, Bacterial (economics, epidemiology, etiology, microbiology)
  • Retrospective Studies
  • Risk Factors
  • Socioeconomic Factors
  • Turkey (epidemiology)
  • Ventriculoperitoneal Shunt (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: